Stocks and Investing
Stocks and Investing
Mon, November 7, 2016
[ 09:45 AM ] - United States, WOPRAI
[ 09:45 AM ] - United States, WOPRAI
[ 07:47 AM ] - United States, WOPRAI
[ 07:47 AM ] - United States, WOPRAI
[ 07:47 AM ] - United States, WOPRAI
[ 07:47 AM ] - United States, WOPRAI
[ 07:47 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 12:45 AM ] - United States, WOPRAI
[ 12:45 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Geoffrey Porges Upgraded (BIIB) to Buy on, Nov 7th, 2016
Geoffrey Porges of Leerink Swann, Upgraded "Biogen Inc." (BIIB) to Buy on, Nov 7th, 2016.
Geoffrey has made no other calls on BIIB in the last 4 months.
There are 2 other peers that have a rating on BIIB. Out of the 2 peers that are also analyzing BIIB, 1 agrees with Geoffrey's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Eun Yang of "Jefferies" Maintained at Hold with Decreased Target to $316 on, Wednesday, October 5th, 2016
This is the rating of the analyst that currently disagrees with Geoffrey
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $368 on, Wednesday, August 17th, 2016
Contributing Sources